Aimmune says peanut allergy drug shows benefit after 2 years
June 08, 2020 at 10:35 AM EDT
Aimmune Therapeutics Inc said on Monday 80% of patients being treated with its drug Palforzia were successfully desensitized to peanut proteins after two years of daily dosing, sending its shares up 6%.